DIHYDROPYRIDINE CALCIUM ANTAGONISTS AND THE TREATMENT OF ARTERIAL HYPERTENSION AND OBESITY PATIENTS IN ACCORDANCE WITH THE MODERN CLINICAL GUIDELINES
This review discusses the potential of a combination antihypertensive therapy with lercanidipine, a dihydropyridine calcium antagonist, for the achievement of target blood pressure levels.
Saved in:
| Main Authors: | S. R. Gilyarevskyi, M. V. Goldschmidt, I. M. Kuzmina |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«FIRMA «SILICEA» LLC
2014-04-01
|
| Series: | Российский кардиологический журнал |
| Subjects: | |
| Online Access: | https://russjcardiol.elpub.ru/jour/article/view/47 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
CALCIUM ANTAGONISTS IN ARTERIAL HYPERTENSION TREATMENT: SPECIFICS OF LERCANIDIPINE
by: I. O. Minushkina
Published: (2015-02-01) -
A modern choice for patients with hypertension: the possibility of new calcium antagonist of III generation
by: E. I. Emelina, et al.
Published: (2015-11-01) -
STROKE PREVENTION OPPORTUNITIES FOR CARDIOLOGISTS: COMPLEX MANAGEMENT OF ARTERIAL HYPERTENSION (ROLE OF CALCIUM ANTAGONISTS)
by: E. O. Taratukhin
Published: (2013-08-01) -
Results of a meta-analysis comparing the tolerability of lercanidipine and other dihydropyridine calcium channel blockers
by: K. Makarounas-Kirchmann, et al.
Published: (2010-12-01) -
Challenges in hypotensive therapy: the role of calcium antagonists
by: E. O. Taratukhin, et al.
Published: (2013-04-01)